Free Trial
NYSE:PRGO

Perrigo (PRGO) Stock Price, News & Analysis

Perrigo logo
$14.51 -0.04 (-0.26%)
Closing price 10/8/2026 03:59 PM Eastern
Extended Trading
$14.34 -0.18 (-1.21%)
As of 04:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Perrigo Stock (NYSE:PRGO)

Advanced

Key Stats

Today's Range
$14.10
▼
$14.56
50-Day Range
$10.09
▼
$15.43
52-Week Range
$9.23
▼
$22.02
Volume
2.88 million shs
Average Volume
2.77 million shs
Market Capitalization
$2.01 billion
P/E Ratio
N/A
Dividend Yield
7.99%
Price Target
$19.33
Consensus Rating
Hold

Company Overview

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products. Perrigo sells through pharmacies, supermarkets, mass retailers, e-commerce channels and other healthcare outlets.

Founded in 1887 in Allegan, Michigan, Perrigo has expanded from a U.S. supplier of private-label medicines into an international consumer health company. It serves customers across North America, Europe and other global markets, with operations and products tailored to regional consumer and regulatory requirements. Patrick Lockwood-Taylor has served as Perrigo’s president and chief executive officer since 2023.

AI Generated. May Contain Errors.

Perrigo Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

PRGO MarketRank™: 

Perrigo scored higher than 59% of companies evaluated by MarketBeat, and ranked 352nd out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Perrigo has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, 4 hold ratings, and 1 sell rating.

  • Upside Potential

    Perrigo has a consensus price target of $19.33, representing about 33.2% upside from its current price of $14.51.

  • Amount of Analyst Coverage

    Perrigo has only been the subject of 1 research reports in the past 90 days.

  • Read more about Perrigo's stock forecast and price target.
  • Earnings Growth

    Earnings for Perrigo are expected to grow by 8.26% in the coming year, from $2.18 to $2.36 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Perrigo is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Perrigo is -1.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Perrigo has a PEG Ratio of 1.67. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Perrigo has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Perrigo's valuation and earnings.
  • Percentage of Shares Shorted

    16.38% of the float of Perrigo has been sold short.
  • Short Interest Ratio / Days to Cover

    Perrigo has a short interest ratio ("days to cover") of 9.34.
  • Change versus previous month

    Short interest in Perrigo has recently increased by 0.35%, indicating that investor sentiment is decreasing.
  • Dividend Leadership

    Perrigo is a leading dividend payer. It pays a dividend yield of 7.97%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Perrigo has been increasing its dividend for 23 years.

  • Dividend Sustainability

    Based on earnings estimates, Perrigo will have a dividend payout ratio of 49.15% next year. This indicates that Perrigo will be able to sustain or increase its dividend.

  • Read more about Perrigo's dividend.
  • Search Interest

    Only 11 people have searched for PRGO on MarketBeat in the last 30 days. This is a decrease of -58% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Perrigo to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Perrigo insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.40% of the stock of Perrigo is held by insiders.

  • Percentage Held by Institutions

    95.91% of the stock of Perrigo is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Perrigo's insider trading history.
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRGO Stock News Headlines

Perrigo Company plc
The Executive Order That Quietly Changed What Your Dollar Means
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel
Perrigo (PRGO) Q2 2026 Earnings Call Transcript
See More Headlines

PRGO Stock Analysis - Frequently Asked Questions

Perrigo's stock was trading at $13.92 at the beginning of the year. Since then, PRGO stock has increased by 4.3% and is now trading at $14.5120.

Perrigo Company plc (NYSE:PRGO) announced its quarterly earnings results on Wednesday, August, 5th. The company reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.11. The firm's revenue for the quarter was down 3.1% on a year-over-year basis.
Read the conference call transcript
.

Perrigo subsidiaries include HRA Pharma, Ranir, Laboratoire de la Mer SAS, Geiss Destin & Dunn, ScarAway, Omega Pharma, Elan Corporation, and more.

Perrigo's top institutional investors include Venture Visionary Partners LLC (0.13%), Parrish Capital LLC (0.03%), GAMMA Investing LLC (0.01%) and Farther Finance Advisors LLC. Insiders that own company stock include Svend Andersen, Eduardo Guarita Bezerra, Robert Willis, Ronald Craig Janish, Patrick Lockwood-Taylor, Geoffrey M Parker, Alison Ives, Katherine C Doyle and Abigail Lennox.
View institutional ownership trends
.

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Perrigo investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Last Earnings
8/05/2026
Record date for 9/15 Dividend
8/28/2026
Ex-Dividend for 9/15 Dividend
8/28/2026
Dividend Payable
9/15/2026
Today
10/09/2026
Next Earnings (Estimated)
11/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PRGO
CIK
1585364
Employees
8,100
Year Founded
1887

Price Target and Rating

High Price Target
$23.00
Low Price Target
$17.00
Potential Upside/Downside
+33.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($12.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
6.66
P/E Growth
1.67
Net Income
-$1.43 billion
Net Margins
-41.85%
Pretax Margin
-38.90%
Return on Equity
11.25%
Return on Assets
4.08%

Debt

Debt-to-Equity Ratio
1.31
Current Ratio
2.32
Quick Ratio
1.32

Sales & Book Value

Annual Sales
$4.14 billion
Price / Sales
0.49
Cash Flow
$5.28 per share
Price / Cash Flow
2.75
Book Value
$21.33 per share
Price / Book
0.68

Miscellaneous

Outstanding Shares
138,769,000
Free Float
138,214,000
Market Cap
$2.01 billion
Optionable
Optionable
Beta
0.69

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:PRGO) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners